Clinical Trial Update: Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a combination of decitabine/cedazuridine with enzalutamide in metastatic castration-resistant prostate cancer has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Decitabine/Cedazuridine (decitabine/cedazuridine)
• Enzalutamide (enzalutamide)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 | Phase 1 | Status: TERMINATED